- Home
- CCBG vs PCRX Comparison
CCBG vs PCRX Comparison
Compare CCBG & PCRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CCBG
- PCRX
- Stock Information
- Founded
- CCBG 1895
- PCRX 2006
- Country
- CCBG United States
- PCRX United States
- Employees
- CCBG N/A
- PCRX N/A
- Industry
- CCBG Major Banks
- PCRX Biotechnology: Pharmaceutical Preparations
- Sector
- CCBG Finance
- PCRX Health Care
- Exchange
- CCBG Nasdaq
- PCRX Nasdaq
- Market Cap
- CCBG 647.6M
- PCRX 1.2B
- IPO Year
- CCBG N/A
- PCRX 2011
- Fundamental
- Price
- CCBG $39.44
- PCRX $24.02
- Analyst Decision
- CCBG Buy
- PCRX Buy
- Analyst Count
- CCBG 2
- PCRX 9
- Target Price
- CCBG $39.00
- PCRX $29.89
- AVG Volume (30 Days)
- CCBG 34.5K
- PCRX 526.9K
- Earning Date
- CCBG 07-22-2025
- PCRX 07-29-2025
- Dividend Yield
- CCBG 2.45%
- PCRX N/A
- EPS Growth
- CCBG 11.98
- PCRX N/A
- EPS
- CCBG 3.37
- PCRX N/A
- Revenue
- CCBG $236,037,000.00
- PCRX $702,772,000.00
- Revenue This Year
- CCBG $10.45
- PCRX $7.54
- Revenue Next Year
- CCBG $3.50
- PCRX $10.78
- P/E Ratio
- CCBG $11.60
- PCRX N/A
- Revenue Growth
- CCBG 6.63
- PCRX 3.08
- 52 Week Low
- CCBG $26.72
- PCRX $11.16
- 52 Week High
- CCBG $40.86
- PCRX $29.33
- Technical
- Relative Strength Index (RSI)
- CCBG 60.24
- PCRX 36.83
- Support Level
- CCBG $35.94
- PCRX $23.85
- Resistance Level
- CCBG $39.14
- PCRX $25.16
- Average True Range (ATR)
- CCBG 0.84
- PCRX 0.79
- MACD
- CCBG 0.14
- PCRX -0.12
- Stochastic Oscillator
- CCBG 89.13
- PCRX 8.20
About CCBG Capital City Bank Group
Capital City Bank Group Inc is a United States-based group engaged in Banking services, Trust and asset management services, and Brokerage services. The company operates in one segment with two principal services: Banking Services and Wealth Management Services. It offers retail and commercial banking business in the form of traditional deposit and credit services, asset management, trust, mortgage banking, merchant services, bank cards, data processing, and securities brokerage services among others through its banking offices in Florida, Georgia, and Alabama.
About PCRX Pacira BioSciences Inc.
Pacira BioSciences Inc is a provider of non-opioid pain management and regenerative health solutions dedicated to advancing and improving outcomes for healthcare practitioners and their patients. The company's commercialized non-opioid treatments: EXPAREL a long-acting, local analgesic currently approved for postsurgical pain management; ZILRETTA, an extended-release, intra-articular, corticosteroid injection indicated for the management of osteoarthritis; and iovera, a novel, handheld device for delivering immediate, long-acting, drug-free pain control using precise, controlled doses of cold temperature to a targeted nerve. In addition, it is developing PCRX-201 (enekinragene inzadenovec), a novel gene therapy vector platform for the treatment of osteoarthritis of the knee.